Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
30000 participants
OBSERVATIONAL
2017-07-03
2020-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Hypertension Registry of "Hypertension Prevention and Control Initiative in China"
NCT04289701
China Rural Hypertension Control Project 2014
NCT02150382
Home Blood Pressure Intervention in the Community Trial
NCT05858944
China Rural Hypertension Control Project
NCT03527719
Controlling Hypertension After Severe Cerebrovascular Event
NCT02982655
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Hospital based hypertension cohort
Antihypertensive Agents
Single or combination therapy with five type of antihypertensive agents, such as Ca channel blockers, ACE inhibitors, ARBs, diuretics, or beta-blockers.
Cardiovascular risk factors
Different level of cardiovascular risk factors associated with genetics, environments and lifestyles.
Community based hypertension cohort
Antihypertensive Agents
Single or combination therapy with five type of antihypertensive agents, such as Ca channel blockers, ACE inhibitors, ARBs, diuretics, or beta-blockers.
Cardiovascular risk factors
Different level of cardiovascular risk factors associated with genetics, environments and lifestyles.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Antihypertensive Agents
Single or combination therapy with five type of antihypertensive agents, such as Ca channel blockers, ACE inhibitors, ARBs, diuretics, or beta-blockers.
Cardiovascular risk factors
Different level of cardiovascular risk factors associated with genetics, environments and lifestyles.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* over 18 years old
* ti sign the informed consent
Exclusion Criteria
* pregnancy or lactating women,or plan to pregnant within half a year,
* with severe mental disorders
* participating in clinical trials
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Beijing Tsinghua Chang Gung Hospital
OTHER
Beijing Tiantan Hospital
OTHER
Ruijin Hospital
OTHER
Nanfang Hospital, Southern Medical University
OTHER
Southwest Hospital, China
OTHER
Beijing Institute of Heart, Lung and Blood Vessel Diseases
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Jing Liu, MD,PhD
Role: PRINCIPAL_INVESTIGATOR
Beijing Institute of Heart, Lung and Blood Vessel Diseases
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Beijing Anzhen Hospital
Beijing, , China
Beijing Tiantan Hospital
Beijing, , China
Beijing Tsinghua Chang Gung Hospital
Beijing, , China
Southwest Hospital, China
Chongqing, , China
Nanfang Hospital of Southern Medical University
Guangzhou, , China
Ruijin Hospital
Shanghai, , China
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Jing Liu
Role: primary
Caixia Guo
Role: primary
Fang Liu
Role: primary
Xinghua Zhang
Role: primary
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2016YFC0900902
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.